AI Verdict
GOOGL has stronger fundamentals based on our AI analysis.
EMED vs GOOGL Fundamental Comparison
| Metric | EMED | GOOGL |
|---|---|---|
| Revenue | $570,415.0 | $402.8B |
| Net Income | $-1.3M | $132.2B |
| Net Margin | -233.1% | 32.8% |
| ROE | N/A | 31.8% |
| ROA | -233.8% | 22.2% |
| Current Ratio | 0.07x | 2.01x |
| Debt/Equity | N/A | 0.12x |
| EPS | $0.00 | $10.81 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
EMED vs GOOGL: Frequently Asked Questions
Is EMED or GOOGL a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GOOGL has stronger fundamentals. EMED is rated STRONG SELL (95% confidence) while GOOGL is rated STRONG BUY (92% confidence). This is not investment advice.
How does EMED compare to GOOGL fundamentally?
Electromedical Technologies, Inc has ROE of N/A vs Alphabet Inc.'s 31.8%. Net margins are -233.1% vs 32.8% respectively.
Which stock pays higher dividends, EMED or GOOGL?
EMED has a dividend yield of N/A or no dividend while GOOGL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in EMED or GOOGL for long term?
For long-term investing, consider that EMED has STRONG SELL rating with 95% confidence, while GOOGL has STRONG BUY rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about EMED vs GOOGL?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EMED vs GOOGL, the AI consensus favors GOOGL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.